Patents Assigned to Health Science Funding, LLC
  • Patent number: 9550804
    Abstract: A way to formulate prasterone to both increase its oral bioavailability, and decrease the variability of its oral bioavailability. In contrast to the approach taught by the prior art, the instant approach is amenable to scale-up to commercial scale. Further, the resulting product is amenable to analysis using standard, known quantitative analytical techniques; thus, unlike the prior art approach, the instant approach may be used to manufacture a product in conformity with applicable regulatory standards.
    Type: Grant
    Filed: August 4, 2014
    Date of Patent: January 24, 2017
    Assignee: Health Science Funding, LLC
    Inventor: J. Mark Pohl
  • Patent number: 8900631
    Abstract: A way to formulate prasterone to both increase its oral bioavailability, and decrease the variability of its oral bioavailability. In contrast to the approach taught by the prior art, the instant approach is amenable to scale-up to commercial scale. Further, the resulting product is amenable to analysis using standard, known quantitative analytical techniques; thus, unlike the prior art approach, the instant approach may be used to manufacture a product in conformity with applicable regulatory standards.
    Type: Grant
    Filed: April 23, 2012
    Date of Patent: December 2, 2014
    Assignee: Health Science Funding, LLC
    Inventor: J. Mark Pohl
  • Publication number: 20140343026
    Abstract: A way to formulate prasterone to both increase its oral bioavailability, and decrease the variability of its oral bioavailability. In contrast to the approach taught by the prior art, the instant approach is amenable to scale-up to commercial scale. Further, the resulting product is amenable to analysis using standard, known quantitative analytical techniques; thus, unlike the prior art approach, the instant approach may be used to manufacture a product in conformity with applicable regulatory standards.
    Type: Application
    Filed: August 4, 2014
    Publication date: November 20, 2014
    Applicant: HEALTH SCIENCE FUNDING, LLC
    Inventor: J. Mark POHL
  • Patent number: 7847112
    Abstract: Novel crystalline forms of anti Pneumocystis carinii compound (2-[4-(4-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone) commonly known as Atovaquone and methods for producing the same is disclosed herein. This also provides pharmaceutical compositions comprising the said polymorphs of Atovaquone and method of treating Pneumocystis carinii pneumonia, the method comprising administering to a warm blooded animal an effective amount of a product-by-process composition of matter comprising polymorphic forms of Atovaquone.
    Type: Grant
    Filed: July 16, 2004
    Date of Patent: December 7, 2010
    Assignee: Health Science Funding, LLC
    Inventors: Narayana Rao Mantripragada, Dhananjay Govind Sathe, Venkatasubramanian Radhakrishnan Tarur, Kamlesh Digambar Sawant, Gautam Ramjibhai Patel